(ABN) ABN Amro - Overview
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0011540547
Stock:
Total Rating 42
Risk 55
Buy Signal -1.08
| Risk 5d forecast | |
|---|---|
| Volatility | 29.3% |
| Relative Tail Risk | -5.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.45 |
| Alpha | 37.86 |
| Character TTM | |
|---|---|
| Beta | 0.727 |
| Beta Downside | 0.906 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.20% |
| CAGR/Max DD | 1.72 |
EPS (Earnings per Share)
Revenue
Description: ABN ABN Amro
ABN AMRO Bank N.V. provides various banking products and financial services to retail, private, and business clients in the Netherlands, rest of Europe, the United States, Asia, and internationally. It operates through three segments: Personal & Business Banking, Wealth Management, and Corporate Banking. The company offers flexible, children's, and automative savings, as well as fixed deposits. It also provides car finance, home improvement, and major purchase loans; mortgage products; investment products; and car, home contents, home, personal liability, annual travel, short-term travel, legal expenses, and student insurances. In addition, the company offers pension savings and investment; asset-based solutions, including working capital solutions, equipment leases and loans, and vendor lease services; clearing services; equity brokerage services; payment and credit cards services; and internet and online banking. The company was incorporated in 2009 and is headquartered in Amsterdam, the Netherlands. ABN AMRO Bank N.V. is a subsidiary of Stichting Administratiekantoor Continuïteit Abn Amro Bank.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: 2.25b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.0 > 0.02 and ΔFCF/TA 3.24 > 1.0 |
| NWC/Revenue: -1568 % < 20% (prev -2362 %; Δ 794.3% < -1%) |
| CFO/TA 0.00 > 3% & CFO 1.03b > Net Income 2.25b |
| Net Debt (29.53b) to EBITDA (3.23b): 9.16 < 3 |
| Current Ratio: 0.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (823.2m) vs 12m ago -1.18% < -2% |
| Gross Margin: 58.78% > 18% (prev 0.74%; Δ 5804 % > 0.5%) |
| Asset Turnover: 3.73% > 50% (prev 2.32%; Δ 1.42% > 0%) |
| Interest Coverage Ratio: 0.37 > 6 (EBITDA TTM 3.23b / Interest Expense TTM 6.14b) |
Altman Z'' -3.64
| A: -0.57 (Total Current Assets 51.53b - Total Current Liabilities 285.08b) / Total Assets 413.21b |
| B: 0.01 (Retained Earnings 2.25b / Total Assets 413.21b) |
| C: 0.01 (EBIT TTM 2.25b / Avg Total Assets 399.13b) |
| D: 0.01 (Book Value of Equity 3.08b / Total Liabilities 386.17b) |
| Altman-Z'' Score: -3.64 = D |
Beneish M
| DSRI: none (Receivables none/3.26b, Revenue 14.89b/8.91b) |
| GMI: 1.25 (GM 58.78% / 73.53%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.67 (Revenue 14.89b / 8.91b) |
| TATA: 0.00 (NI 2.25b - CFO 1.03b) / TA 413.21b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ABN shares?
As of March 04, 2026, the stock is trading at EUR 27.21 with a total of 3,191,153 shares traded.
Over the past week, the price has changed by -3.54%, over one month by -15.39%, over three months by -7.35% and over the past year by +57.79%.
Over the past week, the price has changed by -3.54%, over one month by -15.39%, over three months by -7.35% and over the past year by +57.79%.
Is ABN a buy, sell or hold?
ABN Amro has no consensus analysts rating.
What are the forecasts/targets for the ABN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33 | 21.4% |
| Analysts Target Price | - | - |
ABN Fundamental Data Overview February 28, 2026
Market Cap USD = 27.85b (23.62b EUR * 1.1794 EUR.USD)
P/E Trailing = 11.7102
P/E Forward = 10.2564
P/S = 2.7153
P/B = 0.8324
P/EG = 2.9952
Revenue TTM = 14.89b EUR
EBIT TTM = 2.25b EUR
EBITDA TTM = 3.23b EUR
Long Term Debt = unknown (none)
Short Term Debt = 17.21b EUR (from shortTermDebt, two quarters ago)
Debt = 79.02b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.53b EUR (from netDebt column, last quarter)
Enterprise Value = 51.11b EUR (23.62b + Debt 79.02b - CCE 51.53b)
Interest Coverage Ratio = 0.37 (Ebit TTM 2.25b / Interest Expense TTM 6.14b)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 51.11b)
FCF Margin = 0.0% (FCF TTM 0.0 / Revenue TTM 14.89b)
Net Margin = 15.12% (Net Income TTM 2.25b / Revenue TTM 14.89b)
Gross Margin = 58.78% ((Revenue TTM 14.89b - Cost of Revenue TTM 6.14b) / Revenue TTM)
Gross Margin QoQ = 56.30% (prev 49.61%)
Tobins Q-Ratio = 0.12 (Enterprise Value 51.11b / Total Assets 413.21b)
Interest Expense / Debt = 2.24% (Interest Expense 1.77b / Debt 79.02b)
Taxrate = 33.22% (204.0m / 614.0m)
NOPAT = 1.51b (EBIT 2.25b * (1 - 33.22%))
Current Ratio = 0.18 (Total Current Assets 51.53b / Total Current Liabilities 285.08b)
Debt / Equity = 2.92 (Debt 79.02b / totalStockholderEquity, last quarter 27.04b)
Debt / EBITDA = 9.16 (Net Debt 29.53b / EBITDA 3.23b)
Debt / FCF = unknown (Net Debt 29.53b / FCF TTM 0.0)
Total Stockholder Equity = 26.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.56% (Net Income 2.25b / Total Assets 413.21b)
RoE = 8.57% (Net Income TTM 2.25b / Total Stockholder Equity 26.29b)
RoCE = 1.76% (EBIT 2.25b / Capital Employed (Total Assets 413.21b - Current Liab 285.08b))
RoIC = 1.37% (NOPAT 1.51b / Invested Capital 110.15b)
WACC = 3.13% (E(23.62b)/V(102.64b) * Re(8.59%) + D(79.02b)/V(102.64b) * Rd(2.24%) * (1-Tc(0.33)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.48%
[DCF] Fair Price = unknown (Cash Flow 0.0)
EPS Correlation: 21.30 | EPS CAGR: 11.08% | SUE: -1.29 | # QB: 0
Revenue Correlation: 59.81 | Revenue CAGR: 21.34% | SUE: 2.21 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.71 | Chg7d=+0.002 | Chg30d=+0.016 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.82 | Chg7d=+0.017 | Chg30d=+0.097 | Revisions Net=-4 | Growth EPS=+15.1% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=3.32 | Chg7d=+0.014 | Chg30d=+0.001 | Revisions Net=-3 | Growth EPS=+17.7% | Growth Revenue=+5.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.1% (Discount Rate 8.6% - Earnings Yield 8.5%)
[Growth] Growth Spread = +6.7% (Analyst 6.7% - Implied 0.1%)
P/E Trailing = 11.7102
P/E Forward = 10.2564
P/S = 2.7153
P/B = 0.8324
P/EG = 2.9952
Revenue TTM = 14.89b EUR
EBIT TTM = 2.25b EUR
EBITDA TTM = 3.23b EUR
Long Term Debt = unknown (none)
Short Term Debt = 17.21b EUR (from shortTermDebt, two quarters ago)
Debt = 79.02b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.53b EUR (from netDebt column, last quarter)
Enterprise Value = 51.11b EUR (23.62b + Debt 79.02b - CCE 51.53b)
Interest Coverage Ratio = 0.37 (Ebit TTM 2.25b / Interest Expense TTM 6.14b)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 51.11b)
FCF Margin = 0.0% (FCF TTM 0.0 / Revenue TTM 14.89b)
Net Margin = 15.12% (Net Income TTM 2.25b / Revenue TTM 14.89b)
Gross Margin = 58.78% ((Revenue TTM 14.89b - Cost of Revenue TTM 6.14b) / Revenue TTM)
Gross Margin QoQ = 56.30% (prev 49.61%)
Tobins Q-Ratio = 0.12 (Enterprise Value 51.11b / Total Assets 413.21b)
Interest Expense / Debt = 2.24% (Interest Expense 1.77b / Debt 79.02b)
Taxrate = 33.22% (204.0m / 614.0m)
NOPAT = 1.51b (EBIT 2.25b * (1 - 33.22%))
Current Ratio = 0.18 (Total Current Assets 51.53b / Total Current Liabilities 285.08b)
Debt / Equity = 2.92 (Debt 79.02b / totalStockholderEquity, last quarter 27.04b)
Debt / EBITDA = 9.16 (Net Debt 29.53b / EBITDA 3.23b)
Debt / FCF = unknown (Net Debt 29.53b / FCF TTM 0.0)
Total Stockholder Equity = 26.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.56% (Net Income 2.25b / Total Assets 413.21b)
RoE = 8.57% (Net Income TTM 2.25b / Total Stockholder Equity 26.29b)
RoCE = 1.76% (EBIT 2.25b / Capital Employed (Total Assets 413.21b - Current Liab 285.08b))
RoIC = 1.37% (NOPAT 1.51b / Invested Capital 110.15b)
WACC = 3.13% (E(23.62b)/V(102.64b) * Re(8.59%) + D(79.02b)/V(102.64b) * Rd(2.24%) * (1-Tc(0.33)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.48%
[DCF] Fair Price = unknown (Cash Flow 0.0)
EPS Correlation: 21.30 | EPS CAGR: 11.08% | SUE: -1.29 | # QB: 0
Revenue Correlation: 59.81 | Revenue CAGR: 21.34% | SUE: 2.21 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.71 | Chg7d=+0.002 | Chg30d=+0.016 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.82 | Chg7d=+0.017 | Chg30d=+0.097 | Revisions Net=-4 | Growth EPS=+15.1% | Growth Revenue=+7.1%
EPS next Year (2027-12-31): EPS=3.32 | Chg7d=+0.014 | Chg30d=+0.001 | Revisions Net=-3 | Growth EPS=+17.7% | Growth Revenue=+5.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.1% (Discount Rate 8.6% - Earnings Yield 8.5%)
[Growth] Growth Spread = +6.7% (Analyst 6.7% - Implied 0.1%)